November 26, 2020 News by Mary Chapman New $100M Program Aims to Improve Diversity in Clinical Trials A new $100-million programĀ aims to improve the diversity of participants in U.S. clinical trials with the ultimate goal of achieving better health outcomes and parity in care for underserved patient populations. The initiative seeks to extend the reach of clinical studies to underserved populations in the nationās urban and rural…
November 4, 2020 News by Mary Chapman Innovation Challenge Seeks Solutions From Entrepreneurs in MS Community A $25,000 contest is inviting entrepreneurs who have multiple sclerosis (MS), or take care of someone with MS, to pitch their non-therapeutic solutions for people with the neurodegenerative disorder. The virtual Innovation Challenge, which takes place in March 2021, is part of a collaboration between patient-powered platform Lyfebulb…
October 19, 2020 News by Mary Chapman Eli Lilly Aquires Disarm, Will Develop SARM1 Program for Axonal Degeneration Eli Lilly has reached an agreement to acquire Disarm Therapeutics, a biotechnology company developing a new class of disease-modifying treatments for patients with axonal degeneration, including those with multiple sclerosis (MS). In its announcement, Lilly committed to advancing Disarm’s prospective therapies, currently in preclinical development.
July 8, 2020 News by Mary Chapman BMS, Dragonfly Working on Immune System-targeting Therapies for MS Dragonfly Therapeutics andĀ Bristol Myers Squibb (BMS) announced an expanded partnership focused on discovering and developing treatment candidates for multiple sclerosis (MS) and neuroinflammation targets. The companies have been working together in therapy research and development for cancer and autoimmune diseases using Dragonflyās proprietary immunotherapy targeting platform.
June 16, 2020 News by Mary Chapman $7.2M NIH Grant Supports Study of MS Diagnostic Biomarker The National Institutes of Health (NIH) awarded a $7.2 million grant to a team led byĀ Cleveland ClinicĀ researchers that will study whether a new biomarker might more accurately diagnoseĀ multiple sclerosis (MS). Grant money will support a study in 400 adults suspected of having MS to determine if the…
June 1, 2020 News by Mary Chapman FDA Updates Rebif Label on Pregnancy and Breastfeeding for MS Patients TheĀ U.S. Food and Drug Administration (FDA) approved adding new safety data on pregnancy and breastfeeding to the U.S. label for Rebif (interferon beta-1a), a disease-modifying treatment for relapsing forms of multiple sclerosis (MS). The label update draws on findings from a large population-based study, together with…
May 28, 2020 News by Mary Chapman World MS Day, May 30, Goes On … But Online Despite the COVID-19Ā pandemic, there are many ways to participate inĀ World MS Day 2020Ā on May 30, set aside to raise awareness about the neurodegenerative disorder that affects more than 2.3 million people globally. Organized by the MS International Federation (MSIF), the event brings together the global…
May 22, 2020 News by Mary Chapman MedTech Breakthrough Cites RxMx and Roche for MS Patient App For a comprehensive support app developed for multiple sclerosis (MS) patients,Ā RxMxĀ and Roche have won the Patient Engagement Innovation Award from Medtech Breakthrough. The fourth annual awards program recognized top health and medical technology products and companies. Healthcare company RxMx and pharmaceutical company Roche collaborated to produce…
May 1, 2020 News by Mary Chapman MS Society of Canada Launches Virtual Fundraising Campaign The Multiple Sclerosis Society of Canada is launching a virtual effort that seeks to connect multiple sclerosis (MS) communities across the country and raise funds for research in observance of Multiple Sclerosis Awareness Month in Canada. As part of the initiative, called #WeChallengeMS, Canadian…
April 28, 2020 News by Mary Chapman Collaborative Program in Canada Offers Exercise and Social Sessions During Pandemic During the COVID-19Ā pandemic, a University of Saskatchewan College of Medicine initiative is offering a free virtual exercise and social connection program to individuals with multiple sclerosis (MS) and other neurological conditions, according toĀ a press release. Called NeuroSask, the initiative is in collaboration with…
April 16, 2020 News by Mary Chapman Fampyra, Aid for Walking, Favored for Inclusion in NHS Scotland After being rejected twice in the last four years, Fampyra (fampridine; marketed as Ampyra in the U.S.) is now being recommended by the Scottish Medicines ConsortiumĀ (SMC) for use in the country’sĀ National Health System (NHS) to treat walking disabilities in adults withĀ multiple sclerosis (MS). Scotland…
April 15, 2020 News by Mary Chapman Two Data-sharing Initiatives Launched Regarding MS and COVID-19 Through two new initiatives, multiple sclerosis (MS) patients and their healthcare providers can contribute to a global effort to study and mitigate the impact of COVID-19 in MS and related disorders. The initiatives are aimed at helping clinicians identify the best way to manage the novel coronavirus in…
March 11, 2020 News by Mary Chapman MSAA Events Focus on Mind-Body Connection to Mark MS Awareness Month The Multiple Sclerosis Association of America (MSAA) is offering a host of educational activities on wellness strategies that address both the mind and body in its efforts to mark Multiple Sclerosis Awareness Month. Each year, a month is set aside to heighten awareness of multiple sclerosis (MS),…
March 5, 2020 News by Mary Chapman MS Society Spotlights Patient Stories for MS Awareness Week, March 8-14 The National Multiple Sclerosis SocietyĀ (NMSS) is markingĀ Multiple Sclerosis Awareness Week, March 8-14, by sharing patientsā stories and encouraging participation in fundraising and advocacy efforts. Each year, a week is set aside to heightenĀ awareness of multiple sclerosis (MS), a neurodegenerative disorder that affects nearly 1 million peopleĀ in…
February 19, 2020 News by Mary Chapman Bike MS Fundraiser Will See Tri Global Energy Back on Saddle for 5th Year Tri Global Energy is again joining with fellow Texans forĀ Bike MS, the nationwide fundraising cycling series of the National Multiple Sclerosis Society (NMSS). Team Wind ForceĀ will saddle up May 16-17 for Bike MS Round-Up Ride 2020. Now in its fifth year, theĀ Dallas area team has…
January 30, 2020 News by Mary Chapman Nonprofits RARE Courage, All Wheels Up Partner on Survey Seeking to Improve Air Travel for Wheelchair Users Kevin Schaefer hadnāt been in an airport since he was 4 years old, so he had been looking forward to flying from his home in Cary, North Carolina, to Anaheim, California, in June for the 2019 Cure SMA Conference. As it turned out, his experience didnāt go as expected.
January 22, 2020 News by Mary Chapman Pilot Study Participant Helping Test Exoskeleton Device for MS Therapy Encouraged by Results Since being diagnosed with multiple sclerosis (MS) 20 years ago, Kathy Miskaās ability to walk has steadily worsened, especially in recent years. As a participant of a pilot study at the Cleveland Clinic Mellen Center for Multiple Sclerosis, however, she is cheered by the effect of…
January 13, 2020 News by Mary Chapman MyHealthTeams, EMD Serono Launch Online Family Planning Resource Center for MS Patients To empower and support prospective mothers withĀ multiple sclerosis (MS), MyHealthTeams ā a free social network for people with chronic medical conditions ā and pharmaceutical EMD Serono have launched the onlineĀ Family Planning Resource Center. The new center operates within the network’s MyMSTeam, and is sponsored in…
December 18, 2019 News by Mary Chapman BrainStorm Cell Therapeutics Wins 2020 āBuzz of BIOā Award For its promising investigational therapeutic approach to neurodegenerative diseases, including progressive multiple sclerosis (MS), BrainStorm Cell Therapeutics is theĀ Buzz of BIO 2020 winnerĀ in the Public Therapeutic Biotech category. The Buzz of BIO contest identifies U.S. companies with groundbreaking, early-stage potential to improve lives. The…
December 11, 2019 News by Mary Chapman Sara Loud to Lead Accelerated Cure Project for MS as New CEO Leadership changes at the Accelerated Cure Project (ACP) for Multiple SclerosisĀ aim to enhance the nonprofit patient-founded organizationās research focus. Robert McBurney has stepped down as president and CEO after eight years to become ACPās first chief research officer. He will continue in the position of research lead for the…
December 4, 2019 News by Mary Chapman National MS Society Establishes Partnership with Jon Strum’s ‘RealTalk MS’ Podcast When Jon Strum began his āRealTalk MSā podcast two years ago, he did not imagine he soon would have thousands of regular listeners in more than 60 countries. Now, Strum’s popular online audio series has a new partner: the National Multiple Sclerosis Society (NMSS). Strum uses his weekly…
November 13, 2019 News by Mary Chapman Sativex, Cannabis Extract for MS Spasticity, Now Available to Select Patients in England The cannabis sativa plant extract SativexĀ is a cost-effective therapy for spasticity in multiple sclerosis (MS) and can be offered to patients in England needing it on at least a monthlong trial basis, the National Institute for Health and Care Excellence (NICE) said in issuing a final…
November 8, 2019 News by Mary Chapman āSoothie Cushionā Designed to Regulate Body Temperature in Travelers With MS, Other Disabilities Newly launched, theĀ Soothie Cushion is designed to provide seating comfort and help regulate the body temperature of travelers with disabilities, including multiple sclerosis (MS) and myasthenia gravis, says its official retailer, Special Needs Group/Special Needs at Sea (SNG). The product is said to offer enduring comfort…
October 23, 2019 News by Mary Chapman MS Among Research and Discussion Topics at 24th World Congress of Neurology Some 4,000 science experts from 126 countries will gather at the 24th World Congress of NeurologyĀ (WCN 2019) to discuss cutting-edgeĀ research, including advances in diseases such as multiple sclerosis (MS). Hosted by the World Federation of Neurology (WFN) and the Emirates Neurology Society,Ā the conference will run Oct. 27ā31,Ā inĀ Dubai,…
October 11, 2019 News by Mary Chapman MS Society in UK Opens ‘Stop MS Appeal,’ Ā£100M Fundraiser to Better Treat Disease Through its Stop MS Appeal campaign, the United Kingdomās MS SocietyĀ seeks to raise Ā£100 million (almost $125 million) within the next decade to advance research and treatments that will stopĀ multiple sclerosis (MS) progression. Over the next three months, the organization will run an extensive advertising campaign…
September 27, 2019 News by Mary Chapman Michiganās Memorial Healthcare First in US to Test NfL in MS Patients Memorial Healthcare Institute for Neurosciences and Multiple SclerosisĀ announced it will become the first U.S. hospital to test a nerve cell-derived component known as neurofilament light chain (NfL) in multiple sclerosis (MS) patients. Led by the Owosso, Michigan, hospitalās chief of neurology and MS director, Rany Aburashed, DO,…
September 24, 2019 News by Mary Chapman MS Society of Canada Running Online Letter Campaign Ahead of Oct. 21 Election Leading up to Canadaās Oct. 21 federal election, the Multiple Sclerosis Society of Canada is urging citizens to write their local candidates, asking for greater support of those living with the neurodegenerative disorder. Called #MakeMSMatter, the Sept. 4 through Oct. 21 online letter-writing drive is an effort to…
August 14, 2019 News by Mary Chapman ‘Burgers to Beat MS’ Fundraiser Set for Aug. 22 at A&W Restaurants Across Canada The 11th annual “Burgers to Beat MS” dayĀ is set for Aug. 22 in Canada, with $2 from each purchase of anĀ A&W Teen BurgerĀ going to the MS Society of Canada to support people living withĀ multiple sclerosisĀ (MS). Supporters may also round up their in-restaurant bill to the nearest…
July 10, 2019 News by Mary Chapman My MSAA Community Marks 3 Years of Supporting and Connecting People with MS This summer marks three years since the Multiple Sclerosis Association of AmericaĀ (MSAA) launched its free online forum, designed to support, inform, and uplift members of the multiple sclerosisĀ community.Ā The organization encourages all affected by MS to make use of this resource. Called My MSAA Community, the platform…
July 1, 2019 News by Mary Chapman PathMaker Neurosystems Wins Franceās Top Prize for Innovation for Spasticity Treatment The developer of an innovative, first-in-class, noninvasive device for the treatment of spasticity in multiple sclerosis (MS) and other conditions has won the 2019 CCI France International Trophy for Innovation. PathMaker Neurosystems was selected from a list of eight finalist companies, which were distinguished among 150 nominees…